Generation Investment Management LLP Lowers Holdings in Veeva Systems Inc. $VEEV

Generation Investment Management LLP trimmed its stake in shares of Veeva Systems Inc. (NYSE:VEEV) by 28.3% during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 577,500 shares of the technology company’s stock after selling 227,511 shares during the period. Veeva Systems comprises 1.1% of Generation Investment Management LLP’s holdings, making the stock its 24th largest position. Generation Investment Management LLP’s holdings in Veeva Systems were worth $166,308,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors also recently bought and sold shares of the company. Crossmark Global Holdings Inc. purchased a new stake in Veeva Systems in the 1st quarter worth approximately $299,000. Cerity Partners LLC lifted its stake in shares of Veeva Systems by 4.2% in the 1st quarter. Cerity Partners LLC now owns 78,416 shares of the technology company’s stock valued at $18,164,000 after purchasing an additional 3,194 shares during the period. Xponance Inc. boosted its holdings in Veeva Systems by 1.3% during the first quarter. Xponance Inc. now owns 29,137 shares of the technology company’s stock worth $6,749,000 after buying an additional 383 shares in the last quarter. Mutual of America Capital Management LLC grew its position in Veeva Systems by 13.8% during the first quarter. Mutual of America Capital Management LLC now owns 3,577 shares of the technology company’s stock valued at $829,000 after buying an additional 433 shares during the period. Finally, Stephens Investment Management Group LLC grew its position in Veeva Systems by 6.2% during the first quarter. Stephens Investment Management Group LLC now owns 70,351 shares of the technology company’s stock valued at $16,295,000 after buying an additional 4,087 shares during the period. 88.20% of the stock is currently owned by hedge funds and other institutional investors.

Veeva Systems Trading Up 1.4%

VEEV stock opened at $295.23 on Monday. Veeva Systems Inc. has a 12-month low of $201.54 and a 12-month high of $310.50. The business’s 50-day moving average is $286.40 and its 200 day moving average is $275.65. The stock has a market cap of $48.39 billion, a price-to-earnings ratio of 60.62, a PEG ratio of 2.22 and a beta of 0.98.

Veeva Systems (NYSE:VEEV) last announced its earnings results on Wednesday, August 27th. The technology company reported $1.26 EPS for the quarter, missing analysts’ consensus estimates of $1.90 by ($0.64). The firm had revenue of $789.08 million for the quarter, compared to analyst estimates of $768.49 million. Veeva Systems had a net margin of 27.29% and a return on equity of 13.72%. Veeva Systems’s revenue was up 16.7% compared to the same quarter last year. During the same period in the previous year, the company earned $1.62 EPS. Veeva Systems has set its Q3 2026 guidance at 1.940-1.950 EPS. FY 2026 guidance at 7.780-7.780 EPS. As a group, equities analysts forecast that Veeva Systems Inc. will post 4.35 EPS for the current fiscal year.

Insider Activity

In related news, SVP Jonathan Faddis sold 720 shares of the company’s stock in a transaction dated Monday, October 6th. The shares were sold at an average price of $298.12, for a total transaction of $214,646.40. Following the completion of the sale, the senior vice president owned 7,868 shares of the company’s stock, valued at approximately $2,345,608.16. This represents a 8.38% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Thomas D. Schwenger sold 3,350 shares of the firm’s stock in a transaction that occurred on Thursday, October 2nd. The stock was sold at an average price of $300.04, for a total transaction of $1,005,134.00. Following the completion of the transaction, the insider directly owned 23,773 shares in the company, valued at $7,132,850.92. This trade represents a 12.35% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders sold 24,665 shares of company stock worth $7,438,000 over the last three months. Insiders own 10.30% of the company’s stock.

Analysts Set New Price Targets

VEEV has been the subject of a number of analyst reports. Truist Financial upped their price objective on shares of Veeva Systems from $268.00 to $275.00 and gave the stock a “hold” rating in a research report on Thursday, August 28th. BTIG Research reaffirmed a “buy” rating and issued a $340.00 price target on shares of Veeva Systems in a report on Friday, October 17th. Barclays upped their price target on Veeva Systems from $300.00 to $325.00 and gave the stock an “overweight” rating in a report on Thursday, August 28th. KeyCorp raised their price objective on Veeva Systems from $285.00 to $325.00 and gave the company an “overweight” rating in a report on Monday, July 14th. Finally, Evercore ISI boosted their price objective on Veeva Systems from $285.00 to $295.00 and gave the company an “in-line” rating in a research report on Thursday, August 28th. Seventeen research analysts have rated the stock with a Buy rating, seven have issued a Hold rating and two have issued a Sell rating to the company’s stock. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average price target of $307.58.

About Veeva Systems

Veeva Systems Inc provides cloud-based software for the life sciences industry. It offers Veeva Commercial Cloud, a suite of software and analytics solutions, such as Veeva customer relationship management (CRM) that enable customer-facing employees at pharmaceutical and biotechnology companies; Veeva Vault PromoMats, an end-to-end content and digital asset management solution; Veeva Vault Medical that provides source of medical content across multiple channels and geographies; Veeva Crossix, an analytics platform for pharmaceutical brands; Veeva OpenData, a customer reference data solution; Veeva Link, a data application that allows link to generate real-time intelligence; and Veeva Compass includes de-identified and longitudinal patient data for the United States.